开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2024-03-30 songgao 来自云南省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：新冠
经验分享：投了一篇，大修返回去了，希望好运

80 0

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2024-03-14 ms9000001232984305 来自广东省

Initial Submission
This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2023-09-17 evolsy 来自四川省

审稿速度:2.0
经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分

97 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2024-02-29 loe1 来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：化药
经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。

97 0

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2024-01-02 ms5000000098138879 来自广东省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：试验;新冠;临床
经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯

83 0

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2023-12-28 ms8000000268543706

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：新冠;临床
经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online

85 0

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2023-12-27 ms8000001944553936 来自广东省

偏重的研究方向：疫苗;新冠;病毒学
经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊

89 0

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2023-09-19 南大来自江苏省

请问这个杂志一审多久？

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2022-06-29 洛洛仔111

惊呆了，一下子变成了20+的杂志Q1。目瞪口呆

103 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196201, encodeId=c5d2219620113, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：新冠 经验分享：投了一篇，大修返回去了，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uSLBKdqq7TRFaLXdGd2VZ7Z93BKRY9uuvO1VCO2D8JOibXs0lRHhPsIP8dAHnnEicll9KS9ib6mPXXBvk9qYovtcg/132, createdBy=717d5291157, createdName=songgao, createdTime=Sat Mar 30 10:34:06 CST 2024, time=2024-03-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2193197, encodeId=4e1b219319e1c, content=Initial Submission This submission is under consideration and cannot be edited 这个状态已经一个多星期了，到底是什么意思啊，有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dfe5649794, createdName=ms9000001232984305, createdTime=Thu Mar 14 15:50:25 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158128, encodeId=3fb62158128a0, content=审稿速度:2.0 经验分享：投稿后1.5个月返回。属于送审后拒稿。问题审稿质量差，2个审稿人，一个稍微有点不专业，一个纯属乱写，编辑没留意见，然后拒稿了。申诉后回复了两句：除审稿人外，编辑也评估过了，缺乏priority……前面有人说“审稿也挺看运气”……感觉确实，不知道IF 12分明年能剩几分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLBUoZhM96Ldz6FKld3310hFrqf7ib0kmfg6Vv1ulWibrX7ibVqaU44xFbQvYQI2ApNVOdZ8aKGrLt1Ag/132, createdBy=54765271965, createdName=evolsy, createdTime=Sun Sep 17 12:09:52 CST 2023, time=2023-09-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190089, encodeId=b921219008959, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：化药 经验分享：我的研究工作量比较大，编辑给了一次大修、一次小修，然后接收。总的来说审稿人给的意见都很中肯，也收获了一些新的点。还投过两个工作量比较小的文章，都没有接收，看来期刊对质量还是有一定要求的。希望期刊保持住12分，毕竟势头不错病毒学排名第二的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=02555536999, createdName=loe1, createdTime=Thu Feb 29 14:13:43 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178696, encodeId=828d21e869660, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：试验;新冠;临床 经验分享：10月投稿，12月初小修，12月底接受，总体速度很快，评审人给的意见中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1178475316, createdName=ms5000000098138879, createdTime=Tue Jan 02 08:47:16 CST 2024, time=2024-01-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2177791, encodeId=653721e7791f7, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：新冠;临床 经验分享：8月底投稿，九月底收到大修意见，11月初修回，12月初接收，半个月online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92e8253121, createdName=ms8000000268543706, createdTime=Thu Dec 28 15:26:32 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177620, encodeId=f12721e7620e0, content=偏重的研究方向：疫苗;新冠;病毒学 经验分享：v i r o l o g y j o u r n a l都是中科院二区，你没道理一直是中科院三区啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Wed Dec 27 21:37:38 CST 2023, time=2023-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2158518, encodeId=1761215851875, content=请问这个杂志一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue Sep 19 16:50:05 CST 2023, time=2023-09-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦)]

2023-06-06 wanzhengwei 来自约旦

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：HIV;病毒学;HPV
经验分享：投稿一个月后大修，返修后一个月接收，较顺利。

112 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务